Filing Flows › Comparisons › DERM vs ARCT
Journey Medical vs Arcturus Therapeutics Holdings: DERM and ARCT compared
Journey Medical is the larger company: $18.5M of revenue in its latest quarter (Q2 2026) against $18.3M for Arcturus Therapeutics Holdings (Q3 2026). Journey Medical is growing faster (+23% against +7% a year earlier). Journey Medical is more profitable, with an operating margin of 2.5% against -50.2%.
Where the money goes: DERM and ARCT
Journey Medical (DERM) · Q2 2026
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Arcturus Therapeutics Holdings (ARCT) · Q3 2026
Arcturus Therapeutics Holdings, Q3 2026: revenue $18.3M (+7% year over year), operating margin -50.2%, net loss $7.4M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
| Journey Medical (DERM) | Arcturus Therapeutics Holdings (ARCT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $18.5M | $18.3M |
| Revenue growth, Y/Y | +23% | +7% |
| Operating margin | 2.5% | -50.2% |
| Net earnings | −$312K | −$7.4M |
| Net margin | -1.7% | -40.5% |
| Operating cash flow | −$1.7M | −$6.9M |
Where the revenue comes from
Journey Medical
- Emrosi: $8.1M (44%)
- Qbrexza: $5.1M (28%)
- Accutane: $3.4M (18%)
- Foam franchise products (Amzeeq & Zilxi): $941K (5%)
Arcturus Therapeutics Holdings
- Collaboration Revenue: $16.9M (92%)
- Grant: $1.4M (8%)
Questions
Which is bigger, Journey Medical or Arcturus Therapeutics Holdings?
Journey Medical is the larger company: $18.5M of revenue in its latest quarter (Q2 2026) against $18.3M for Arcturus Therapeutics Holdings (Q3 2026).
Is Journey Medical or Arcturus Therapeutics Holdings growing faster?
Journey Medical is growing faster (+23% against +7% a year earlier).
Which is more profitable, Journey Medical or Arcturus Therapeutics Holdings?
Journey Medical is more profitable, with an operating margin of 2.5% against -50.2%.
More: Journey Medical earnings · how Journey Medical makes money · Arcturus Therapeutics Holdings earnings · how Arcturus Therapeutics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.